NCT02910739
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Amnestic Mild Cognitive Impairment, +9 more
- Locations
-
Not specified
Clinical trial condition
Neurocognitive Disorders
Explore clinical trials studying Neurocognitive Disorders. Study availability and eligibility vary by location and protocol.
7,764 public trials
1,431 recruiting studies
Neurocognitive Disorders trial results
NCT03690193
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
Not specified
Completed
Feasibility Study of Neurofeedback Training for Older Adults With Mild Cognitive Impairment
NCT03686839
- Conditions
- Cognition Disorders, Cognitive Dysfunction, Mental Disorders, +2 more
- Locations
-
- Anne-Sophie Rigaud Paris, France
NCT01059877
- Conditions
- Brain Diseases, Central Nervous System Diseases, Dementia, +3 more
- Locations
-
- Quietmind Foundation Plymouth Meeting, Pennsylvania, United States
Completed
Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases.
NCT02750982
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Amyotrophic Lateral Sclerosis, +46 more
- Locations
-
- Evergreen Healthcare Kirkland, Washington, United States
NCT03208517
- Conditions
- Brain Diseases, Central Nervous System Diseases, Dementia, +3 more
- Locations
-
- King's College London London, United Kingdom
NCT03286439
- Conditions
- Cognition Disorders, Cognitive Deficit, Mental Disorders, +1 more
- Locations
-
- Zealand University Hospital Køge, Denmark
NCT01428453
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
- Locations
-
- GSK Investigational Site Sofia, Bulgaria
- GSK Investigational Site Sofia, Bulgaria
- GSK Investigational Site Toronto, Ontario, Canada
- GSK Investigational Site Gatineau, Quebec, Canada
NCT02597569
- Conditions
- Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +8 more
- Locations
-
- Providence Healthcare Toronto, Ontario, Canada
- Sunnybrook Health Sciences Centre - St. John's Rehab Toronto, Ontario, Canada
- Bridgepoint Active Healthcare Toronto, Ontario, Canada
- Toronto Rehabilitation Institute Toronto, Ontario, Canada
Completed
[18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001)
NCT02562989
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Amnestic Mild Cognitive Impairment, +8 more
- Locations
-
Not specified